Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 20, 2022
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
[ Tue, Sep 20th 2022
] - WOPRAI
Mon, September 19, 2022
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
[ Mon, Sep 19th 2022
] - WOPRAI
Gobind Singh Initiated (ANAB) at Strong Buy and Held Target at $35 on, Sep 19th, 2022
Gobind Singh of HC Wainwright & Co., Initiated "AnaptysBio, Inc." (ANAB) at Strong Buy and Held Target at $35 on, Sep 19th, 2022.
Gobind has made no other calls on ANAB in the last 4 months.
There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 1 agrees with Gobind's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Lee of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Tuesday, September 13th, 2022
This is the rating of the analyst that currently disagrees with Gobind
- Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $35 on, Thursday, September 1st, 2022
